Author

Muhammed M. Salahuddin

Observed name: Muhammed M Salahuddin

Institution: Horus University – Egypt

Observed institutions: Damanhour University, Horus University – Egypt

ORCID: 0000-0001-7464-1706

Observed ORCID: 0000-0001-7464-1706

OpenAlex ID: A5024808699

Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib

2021 · Muhammed M. Salahuddin, Gamal A. Omran, et al. · Current Issues in Molecular Biology · 22

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

2024 · Khlood Mohammad Aldossary, Lashin Saad Ali, et al. · Frontiers in Pharmacology · 20

Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study

2024 · Sumaiah J Alarfaj, Mostafa M Bahaa, et al. · Drug Design Development and Therapy · 17

Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson’s disease

2025 · Hayam Ali AlRasheed, Mostafa M. Bahaa, et al. · Frontiers in Pharmacology · 16

Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study

2025 · Mohannad O. Khrieba, Furqan M. Abdulelah, et al. · Frontiers in Pharmacology · 6

A randomized controlled trial comparing tacrolimus versus hydrocortisone for the treatment of atopic dermatitis in children: new perspectives on interferon gamma-induced protein and growth-related oncogene-α

2024 · Ammena Y. Binsaleh, Mostafa M. Bahaa, et al. · Frontiers in Medicine · 6

Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

2024 · Khlood Mohammad Aldossary, Lashin Saad Ali, et al. · Frontiers in Pharmacology · 5

Correlation between depression scores and serum NF ‐ ĸB / NLRP3 axis, biotinidase, and HMGB1 after treatment with isotretinoin in patients with acne vulgaris

2024 · Ammena Y. Binsaleh, Lahin Saad Ali, et al. · Journal of Cosmetic Dermatology · 5

Colo‐Protective Effects of Pentoxifylline Alone or in Combination With Mesalamine in Colitis Through Sphingosine Kinase 1/Sphingosine 1 Phosphate, and Zonula Occuldin 1 Pathways: New Molecular Approach

2025 · Fatemah A. Alherz, Mahmoud S. Abdallah, et al. · Pharmacology Research & Perspectives · 3

Vardenafil Alleviates Doxorubicin-Induced Cardiotoxicity Associated with Restoration of the AMPK/SIRT1 Signaling Pathway

2026 · Eman H. Yousef, Mohamad A. El-Gammal, et al. · Biomedicines

Norcantharidin attenuates amiodarone-induced pulmonary fibrosis via modulating miRNA-30a/GSK-3β/β-catenin and oxidative–inflammatory pathways

2026 · Ahmed G. Abd Elhameed, Eman H. Yousef, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology

Cilostazol mitigates amiodarone-induced pulmonary toxicity and fibrosis by regulating the cAMP/TGF-β1 pathway-mediated epithelial-to-mesenchymal transition in rats

2026 · Mohamad A. El-Gammal, Eman H. Yousef, et al. · Scientific Reports

Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial

2026 · Mohannad O. Khrieba, Furqan M. Abdulelah, et al. · Pharmaceuticals

Modulation of mTOR, NLRP3, and Nrf2/HO-1 signaling by atorvastatin and nitazoxanide in experimental ulcerative colitis

2026 · Hayam Ali AlRasheed, Mahmoud S. Abdallah, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology

Works count: 14

Citation count: 100

H-index: 6

I10-index: 4